nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Ibuprofen—Melphalan—breast cancer	0.608	1	CrCrCtD
Sotalol—Ibuprofen—BCL2—breast cancer	0.000776	0.182	CrCbGaD
Sotalol—Ibuprofen—ABCC1—breast cancer	0.000704	0.165	CrCbGaD
Sotalol—Ibuprofen—CXCL8—breast cancer	0.000622	0.146	CrCbGaD
Sotalol—Metoprolol—CYP2D6—breast cancer	0.000377	0.0884	CrCbGaD
Sotalol—Isoprenaline—CYP1A1—breast cancer	0.00036	0.0843	CrCbGaD
Sotalol—Atenolol—ABCB1—breast cancer	0.000346	0.081	CrCbGaD
Sotalol—Ibuprofen—PTGS1—breast cancer	0.000318	0.0744	CrCbGaD
Sotalol—Metoprolol—ABCB1—breast cancer	0.000269	0.0631	CrCbGaD
Sotalol—Ibuprofen—PTGS2—breast cancer	0.000182	0.0425	CrCbGaD
Sotalol—Ibuprofen—ALB—breast cancer	0.000162	0.0379	CrCbGaD
Sotalol—Ibuprofen—ABCB1—breast cancer	0.000154	0.0362	CrCbGaD
Sotalol—Nausea—Vinorelbine—breast cancer	0.00011	0.000319	CcSEcCtD
Sotalol—Dyspepsia—Paclitaxel—breast cancer	0.00011	0.000318	CcSEcCtD
Sotalol—Asthenia—Irinotecan—breast cancer	0.00011	0.000318	CcSEcCtD
Sotalol—Asthenia—Mitoxantrone—breast cancer	0.00011	0.000318	CcSEcCtD
Sotalol—Neuropathy peripheral—Epirubicin—breast cancer	0.000109	0.000317	CcSEcCtD
Sotalol—Cough—Capecitabine—breast cancer	0.000109	0.000317	CcSEcCtD
Sotalol—Decreased appetite—Paclitaxel—breast cancer	0.000108	0.000314	CcSEcCtD
Sotalol—Hypertension—Capecitabine—breast cancer	0.000108	0.000314	CcSEcCtD
Sotalol—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000108	0.000312	CcSEcCtD
Sotalol—Haemoglobin—Methotrexate—breast cancer	0.000108	0.000312	CcSEcCtD
Sotalol—Fatigue—Paclitaxel—breast cancer	0.000107	0.000311	CcSEcCtD
Sotalol—Haemorrhage—Methotrexate—breast cancer	0.000107	0.000311	CcSEcCtD
Sotalol—Asthenia—Gemcitabine—breast cancer	0.000107	0.00031	CcSEcCtD
Sotalol—Chest pain—Capecitabine—breast cancer	0.000107	0.000309	CcSEcCtD
Sotalol—Myalgia—Capecitabine—breast cancer	0.000107	0.000309	CcSEcCtD
Sotalol—Pain—Paclitaxel—breast cancer	0.000106	0.000309	CcSEcCtD
Sotalol—Anxiety—Capecitabine—breast cancer	0.000106	0.000308	CcSEcCtD
Sotalol—Photosensitivity reaction—Doxorubicin—breast cancer	0.000106	0.000307	CcSEcCtD
Sotalol—Oedema—Docetaxel—breast cancer	0.000106	0.000306	CcSEcCtD
Sotalol—Pruritus—Gemcitabine—breast cancer	0.000105	0.000305	CcSEcCtD
Sotalol—Nausea—Thiotepa—breast cancer	0.000105	0.000305	CcSEcCtD
Sotalol—Infection—Docetaxel—breast cancer	0.000105	0.000304	CcSEcCtD
Sotalol—Hyperglycaemia—Doxorubicin—breast cancer	0.000104	0.000303	CcSEcCtD
Sotalol—Diarrhoea—Mitoxantrone—breast cancer	0.000104	0.000303	CcSEcCtD
Sotalol—Diarrhoea—Irinotecan—breast cancer	0.000104	0.000303	CcSEcCtD
Sotalol—Agranulocytosis—Epirubicin—breast cancer	0.000104	0.000302	CcSEcCtD
Sotalol—Shock—Docetaxel—breast cancer	0.000104	0.000301	CcSEcCtD
Sotalol—Pruritus—Fluorouracil—breast cancer	0.000103	0.0003	CcSEcCtD
Sotalol—Thrombocytopenia—Docetaxel—breast cancer	0.000103	0.0003	CcSEcCtD
Sotalol—Drowsiness—Doxorubicin—breast cancer	0.000103	0.0003	CcSEcCtD
Sotalol—Visual impairment—Methotrexate—breast cancer	0.000103	0.000299	CcSEcCtD
Sotalol—Oedema—Capecitabine—breast cancer	0.000102	0.000296	CcSEcCtD
Sotalol—Bradycardia—Epirubicin—breast cancer	0.000102	0.000296	CcSEcCtD
Sotalol—Gastrointestinal pain—Paclitaxel—breast cancer	0.000102	0.000295	CcSEcCtD
Sotalol—Diarrhoea—Gemcitabine—breast cancer	0.000102	0.000295	CcSEcCtD
Sotalol—Infection—Capecitabine—breast cancer	0.000101	0.000294	CcSEcCtD
Sotalol—Neuropathy peripheral—Doxorubicin—breast cancer	0.000101	0.000294	CcSEcCtD
Sotalol—Dizziness—Irinotecan—breast cancer	0.000101	0.000293	CcSEcCtD
Sotalol—Haemoglobin—Epirubicin—breast cancer	0.000101	0.000292	CcSEcCtD
Sotalol—Shock—Capecitabine—breast cancer	0.000101	0.000292	CcSEcCtD
Sotalol—Haemorrhage—Epirubicin—breast cancer	0.0001	0.000291	CcSEcCtD
Sotalol—Diarrhoea—Fluorouracil—breast cancer	0.0001	0.00029	CcSEcCtD
Sotalol—Thrombocytopenia—Capecitabine—breast cancer	0.0001	0.00029	CcSEcCtD
Sotalol—Hyperhidrosis—Capecitabine—breast cancer	9.88e-05	0.000287	CcSEcCtD
Sotalol—Hypotension—Docetaxel—breast cancer	9.86e-05	0.000286	CcSEcCtD
Sotalol—Abdominal pain—Paclitaxel—breast cancer	9.84e-05	0.000286	CcSEcCtD
Sotalol—Body temperature increased—Paclitaxel—breast cancer	9.84e-05	0.000286	CcSEcCtD
Sotalol—Angiopathy—Methotrexate—breast cancer	9.71e-05	0.000282	CcSEcCtD
Sotalol—Vomiting—Irinotecan—breast cancer	9.7e-05	0.000282	CcSEcCtD
Sotalol—Vomiting—Mitoxantrone—breast cancer	9.7e-05	0.000282	CcSEcCtD
Sotalol—Dizziness—Fluorouracil—breast cancer	9.67e-05	0.000281	CcSEcCtD
Sotalol—Visual impairment—Epirubicin—breast cancer	9.65e-05	0.00028	CcSEcCtD
Sotalol—Agranulocytosis—Doxorubicin—breast cancer	9.63e-05	0.00028	CcSEcCtD
Sotalol—Rash—Mitoxantrone—breast cancer	9.62e-05	0.000279	CcSEcCtD
Sotalol—Rash—Irinotecan—breast cancer	9.62e-05	0.000279	CcSEcCtD
Sotalol—Dermatitis—Mitoxantrone—breast cancer	9.61e-05	0.000279	CcSEcCtD
Sotalol—Dermatitis—Irinotecan—breast cancer	9.61e-05	0.000279	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Docetaxel—breast cancer	9.61e-05	0.000279	CcSEcCtD
Sotalol—Headache—Irinotecan—breast cancer	9.56e-05	0.000277	CcSEcCtD
Sotalol—Headache—Mitoxantrone—breast cancer	9.56e-05	0.000277	CcSEcCtD
Sotalol—Hypotension—Capecitabine—breast cancer	9.55e-05	0.000277	CcSEcCtD
Sotalol—Insomnia—Docetaxel—breast cancer	9.54e-05	0.000277	CcSEcCtD
Sotalol—Paraesthesia—Docetaxel—breast cancer	9.47e-05	0.000275	CcSEcCtD
Sotalol—Alopecia—Methotrexate—breast cancer	9.46e-05	0.000274	CcSEcCtD
Sotalol—Vomiting—Gemcitabine—breast cancer	9.45e-05	0.000274	CcSEcCtD
Sotalol—Bradycardia—Doxorubicin—breast cancer	9.44e-05	0.000274	CcSEcCtD
Sotalol—Dyspnoea—Docetaxel—breast cancer	9.41e-05	0.000273	CcSEcCtD
Sotalol—Somnolence—Docetaxel—breast cancer	9.38e-05	0.000272	CcSEcCtD
Sotalol—Rash—Gemcitabine—breast cancer	9.37e-05	0.000272	CcSEcCtD
Sotalol—Dermatitis—Gemcitabine—breast cancer	9.37e-05	0.000272	CcSEcCtD
Sotalol—Haemoglobin—Doxorubicin—breast cancer	9.32e-05	0.00027	CcSEcCtD
Sotalol—Headache—Gemcitabine—breast cancer	9.31e-05	0.00027	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Capecitabine—breast cancer	9.31e-05	0.00027	CcSEcCtD
Sotalol—Vomiting—Fluorouracil—breast cancer	9.29e-05	0.00027	CcSEcCtD
Sotalol—Dyspepsia—Docetaxel—breast cancer	9.29e-05	0.00027	CcSEcCtD
Sotalol—Haemorrhage—Doxorubicin—breast cancer	9.27e-05	0.000269	CcSEcCtD
Sotalol—Insomnia—Capecitabine—breast cancer	9.24e-05	0.000268	CcSEcCtD
Sotalol—Rash—Fluorouracil—breast cancer	9.22e-05	0.000267	CcSEcCtD
Sotalol—Dermatitis—Fluorouracil—breast cancer	9.21e-05	0.000267	CcSEcCtD
Sotalol—Paraesthesia—Capecitabine—breast cancer	9.17e-05	0.000266	CcSEcCtD
Sotalol—Decreased appetite—Docetaxel—breast cancer	9.17e-05	0.000266	CcSEcCtD
Sotalol—Headache—Fluorouracil—breast cancer	9.16e-05	0.000266	CcSEcCtD
Sotalol—Dysgeusia—Methotrexate—breast cancer	9.12e-05	0.000265	CcSEcCtD
Sotalol—Dyspnoea—Capecitabine—breast cancer	9.11e-05	0.000264	CcSEcCtD
Sotalol—Fatigue—Docetaxel—breast cancer	9.1e-05	0.000264	CcSEcCtD
Sotalol—Angiopathy—Epirubicin—breast cancer	9.09e-05	0.000264	CcSEcCtD
Sotalol—Nausea—Mitoxantrone—breast cancer	9.07e-05	0.000263	CcSEcCtD
Sotalol—Nausea—Irinotecan—breast cancer	9.07e-05	0.000263	CcSEcCtD
Sotalol—Pain—Docetaxel—breast cancer	9.02e-05	0.000262	CcSEcCtD
Sotalol—Back pain—Methotrexate—breast cancer	9.01e-05	0.000262	CcSEcCtD
Sotalol—Dyspepsia—Capecitabine—breast cancer	8.99e-05	0.000261	CcSEcCtD
Sotalol—Arrhythmia—Epirubicin—breast cancer	8.95e-05	0.00026	CcSEcCtD
Sotalol—Visual impairment—Doxorubicin—breast cancer	8.93e-05	0.000259	CcSEcCtD
Sotalol—Asthenia—Paclitaxel—breast cancer	8.93e-05	0.000259	CcSEcCtD
Sotalol—Decreased appetite—Capecitabine—breast cancer	8.88e-05	0.000258	CcSEcCtD
Sotalol—Alopecia—Epirubicin—breast cancer	8.85e-05	0.000257	CcSEcCtD
Sotalol—Nausea—Gemcitabine—breast cancer	8.83e-05	0.000256	CcSEcCtD
Sotalol—Fatigue—Capecitabine—breast cancer	8.81e-05	0.000256	CcSEcCtD
Sotalol—Pruritus—Paclitaxel—breast cancer	8.81e-05	0.000256	CcSEcCtD
Sotalol—Vision blurred—Methotrexate—breast cancer	8.78e-05	0.000255	CcSEcCtD
Sotalol—Pain—Capecitabine—breast cancer	8.74e-05	0.000253	CcSEcCtD
Sotalol—Nausea—Fluorouracil—breast cancer	8.68e-05	0.000252	CcSEcCtD
Sotalol—Gastrointestinal pain—Docetaxel—breast cancer	8.63e-05	0.00025	CcSEcCtD
Sotalol—Flatulence—Epirubicin—breast cancer	8.59e-05	0.000249	CcSEcCtD
Sotalol—Dysgeusia—Epirubicin—breast cancer	8.54e-05	0.000248	CcSEcCtD
Sotalol—Diarrhoea—Paclitaxel—breast cancer	8.52e-05	0.000247	CcSEcCtD
Sotalol—Back pain—Epirubicin—breast cancer	8.43e-05	0.000245	CcSEcCtD
Sotalol—Angiopathy—Doxorubicin—breast cancer	8.41e-05	0.000244	CcSEcCtD
Sotalol—Muscle spasms—Epirubicin—breast cancer	8.38e-05	0.000243	CcSEcCtD
Sotalol—Vertigo—Methotrexate—breast cancer	8.37e-05	0.000243	CcSEcCtD
Sotalol—Gastrointestinal pain—Capecitabine—breast cancer	8.35e-05	0.000242	CcSEcCtD
Sotalol—Body temperature increased—Docetaxel—breast cancer	8.34e-05	0.000242	CcSEcCtD
Sotalol—Abdominal pain—Docetaxel—breast cancer	8.34e-05	0.000242	CcSEcCtD
Sotalol—Leukopenia—Methotrexate—breast cancer	8.34e-05	0.000242	CcSEcCtD
Sotalol—Arrhythmia—Doxorubicin—breast cancer	8.28e-05	0.00024	CcSEcCtD
Sotalol—Dizziness—Paclitaxel—breast cancer	8.23e-05	0.000239	CcSEcCtD
Sotalol—Vision blurred—Epirubicin—breast cancer	8.22e-05	0.000238	CcSEcCtD
Sotalol—Alopecia—Doxorubicin—breast cancer	8.19e-05	0.000238	CcSEcCtD
Sotalol—Cough—Methotrexate—breast cancer	8.13e-05	0.000236	CcSEcCtD
Sotalol—Abdominal pain—Capecitabine—breast cancer	8.08e-05	0.000234	CcSEcCtD
Sotalol—Body temperature increased—Capecitabine—breast cancer	8.08e-05	0.000234	CcSEcCtD
Sotalol—Flatulence—Doxorubicin—breast cancer	7.95e-05	0.000231	CcSEcCtD
Sotalol—Myalgia—Methotrexate—breast cancer	7.93e-05	0.00023	CcSEcCtD
Sotalol—Chest pain—Methotrexate—breast cancer	7.93e-05	0.00023	CcSEcCtD
Sotalol—Vomiting—Paclitaxel—breast cancer	7.91e-05	0.00023	CcSEcCtD
Sotalol—Dysgeusia—Doxorubicin—breast cancer	7.9e-05	0.000229	CcSEcCtD
Sotalol—Rash—Paclitaxel—breast cancer	7.85e-05	0.000228	CcSEcCtD
Sotalol—Dermatitis—Paclitaxel—breast cancer	7.84e-05	0.000228	CcSEcCtD
Sotalol—Vertigo—Epirubicin—breast cancer	7.83e-05	0.000227	CcSEcCtD
Sotalol—Syncope—Epirubicin—breast cancer	7.82e-05	0.000227	CcSEcCtD
Sotalol—Leukopenia—Epirubicin—breast cancer	7.81e-05	0.000226	CcSEcCtD
Sotalol—Back pain—Doxorubicin—breast cancer	7.8e-05	0.000226	CcSEcCtD
Sotalol—Headache—Paclitaxel—breast cancer	7.8e-05	0.000226	CcSEcCtD
Sotalol—Muscle spasms—Doxorubicin—breast cancer	7.76e-05	0.000225	CcSEcCtD
Sotalol—Palpitations—Epirubicin—breast cancer	7.71e-05	0.000224	CcSEcCtD
Sotalol—Loss of consciousness—Epirubicin—breast cancer	7.66e-05	0.000222	CcSEcCtD
Sotalol—Cough—Epirubicin—breast cancer	7.61e-05	0.000221	CcSEcCtD
Sotalol—Vision blurred—Doxorubicin—breast cancer	7.6e-05	0.000221	CcSEcCtD
Sotalol—Asthenia—Docetaxel—breast cancer	7.57e-05	0.00022	CcSEcCtD
Sotalol—Infection—Methotrexate—breast cancer	7.55e-05	0.000219	CcSEcCtD
Sotalol—Hypertension—Epirubicin—breast cancer	7.53e-05	0.000218	CcSEcCtD
Sotalol—Pruritus—Docetaxel—breast cancer	7.46e-05	0.000217	CcSEcCtD
Sotalol—Thrombocytopenia—Methotrexate—breast cancer	7.45e-05	0.000216	CcSEcCtD
Sotalol—Myalgia—Epirubicin—breast cancer	7.42e-05	0.000215	CcSEcCtD
Sotalol—Chest pain—Epirubicin—breast cancer	7.42e-05	0.000215	CcSEcCtD
Sotalol—Anxiety—Epirubicin—breast cancer	7.4e-05	0.000215	CcSEcCtD
Sotalol—Nausea—Paclitaxel—breast cancer	7.39e-05	0.000215	CcSEcCtD
Sotalol—Hyperhidrosis—Methotrexate—breast cancer	7.35e-05	0.000213	CcSEcCtD
Sotalol—Asthenia—Capecitabine—breast cancer	7.33e-05	0.000213	CcSEcCtD
Sotalol—Vertigo—Doxorubicin—breast cancer	7.25e-05	0.00021	CcSEcCtD
Sotalol—Syncope—Doxorubicin—breast cancer	7.24e-05	0.00021	CcSEcCtD
Sotalol—Pruritus—Capecitabine—breast cancer	7.23e-05	0.00021	CcSEcCtD
Sotalol—Leukopenia—Doxorubicin—breast cancer	7.22e-05	0.00021	CcSEcCtD
Sotalol—Diarrhoea—Docetaxel—breast cancer	7.22e-05	0.000209	CcSEcCtD
Sotalol—Palpitations—Doxorubicin—breast cancer	7.13e-05	0.000207	CcSEcCtD
Sotalol—Oedema—Epirubicin—breast cancer	7.12e-05	0.000207	CcSEcCtD
Sotalol—Hypotension—Methotrexate—breast cancer	7.11e-05	0.000206	CcSEcCtD
Sotalol—Loss of consciousness—Doxorubicin—breast cancer	7.09e-05	0.000206	CcSEcCtD
Sotalol—Infection—Epirubicin—breast cancer	7.07e-05	0.000205	CcSEcCtD
Sotalol—Cough—Doxorubicin—breast cancer	7.04e-05	0.000204	CcSEcCtD
Sotalol—Shock—Epirubicin—breast cancer	7e-05	0.000203	CcSEcCtD
Sotalol—Diarrhoea—Capecitabine—breast cancer	6.99e-05	0.000203	CcSEcCtD
Sotalol—Dizziness—Docetaxel—breast cancer	6.98e-05	0.000202	CcSEcCtD
Sotalol—Thrombocytopenia—Epirubicin—breast cancer	6.97e-05	0.000202	CcSEcCtD
Sotalol—Hypertension—Doxorubicin—breast cancer	6.97e-05	0.000202	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Methotrexate—breast cancer	6.93e-05	0.000201	CcSEcCtD
Sotalol—Hyperhidrosis—Epirubicin—breast cancer	6.88e-05	0.0002	CcSEcCtD
Sotalol—Insomnia—Methotrexate—breast cancer	6.88e-05	0.0002	CcSEcCtD
Sotalol—Chest pain—Doxorubicin—breast cancer	6.87e-05	0.000199	CcSEcCtD
Sotalol—Myalgia—Doxorubicin—breast cancer	6.87e-05	0.000199	CcSEcCtD
Sotalol—Anxiety—Doxorubicin—breast cancer	6.85e-05	0.000199	CcSEcCtD
Sotalol—Paraesthesia—Methotrexate—breast cancer	6.83e-05	0.000198	CcSEcCtD
Sotalol—Dyspnoea—Methotrexate—breast cancer	6.78e-05	0.000197	CcSEcCtD
Sotalol—Somnolence—Methotrexate—breast cancer	6.76e-05	0.000196	CcSEcCtD
Sotalol—Dizziness—Capecitabine—breast cancer	6.76e-05	0.000196	CcSEcCtD
Sotalol—Vomiting—Docetaxel—breast cancer	6.71e-05	0.000195	CcSEcCtD
Sotalol—Dyspepsia—Methotrexate—breast cancer	6.69e-05	0.000194	CcSEcCtD
Sotalol—Rash—Docetaxel—breast cancer	6.65e-05	0.000193	CcSEcCtD
Sotalol—Hypotension—Epirubicin—breast cancer	6.65e-05	0.000193	CcSEcCtD
Sotalol—Dermatitis—Docetaxel—breast cancer	6.65e-05	0.000193	CcSEcCtD
Sotalol—Decreased appetite—Methotrexate—breast cancer	6.61e-05	0.000192	CcSEcCtD
Sotalol—Headache—Docetaxel—breast cancer	6.61e-05	0.000192	CcSEcCtD
Sotalol—Oedema—Doxorubicin—breast cancer	6.58e-05	0.000191	CcSEcCtD
Sotalol—Fatigue—Methotrexate—breast cancer	6.56e-05	0.00019	CcSEcCtD
Sotalol—Infection—Doxorubicin—breast cancer	6.54e-05	0.00019	CcSEcCtD
Sotalol—Pain—Methotrexate—breast cancer	6.5e-05	0.000189	CcSEcCtD
Sotalol—Vomiting—Capecitabine—breast cancer	6.5e-05	0.000188	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Epirubicin—breast cancer	6.48e-05	0.000188	CcSEcCtD
Sotalol—Shock—Doxorubicin—breast cancer	6.48e-05	0.000188	CcSEcCtD
Sotalol—Thrombocytopenia—Doxorubicin—breast cancer	6.45e-05	0.000187	CcSEcCtD
Sotalol—Rash—Capecitabine—breast cancer	6.44e-05	0.000187	CcSEcCtD
Sotalol—Insomnia—Epirubicin—breast cancer	6.44e-05	0.000187	CcSEcCtD
Sotalol—Dermatitis—Capecitabine—breast cancer	6.44e-05	0.000187	CcSEcCtD
Sotalol—Headache—Capecitabine—breast cancer	6.4e-05	0.000186	CcSEcCtD
Sotalol—Paraesthesia—Epirubicin—breast cancer	6.39e-05	0.000185	CcSEcCtD
Sotalol—Hyperhidrosis—Doxorubicin—breast cancer	6.37e-05	0.000185	CcSEcCtD
Sotalol—Dyspnoea—Epirubicin—breast cancer	6.34e-05	0.000184	CcSEcCtD
Sotalol—Somnolence—Epirubicin—breast cancer	6.33e-05	0.000184	CcSEcCtD
Sotalol—Nausea—Docetaxel—breast cancer	6.27e-05	0.000182	CcSEcCtD
Sotalol—Dyspepsia—Epirubicin—breast cancer	6.26e-05	0.000182	CcSEcCtD
Sotalol—Gastrointestinal pain—Methotrexate—breast cancer	6.22e-05	0.00018	CcSEcCtD
Sotalol—Decreased appetite—Epirubicin—breast cancer	6.19e-05	0.00018	CcSEcCtD
Sotalol—Hypotension—Doxorubicin—breast cancer	6.15e-05	0.000179	CcSEcCtD
Sotalol—Fatigue—Epirubicin—breast cancer	6.14e-05	0.000178	CcSEcCtD
Sotalol—Pain—Epirubicin—breast cancer	6.09e-05	0.000177	CcSEcCtD
Sotalol—Nausea—Capecitabine—breast cancer	6.07e-05	0.000176	CcSEcCtD
Sotalol—Body temperature increased—Methotrexate—breast cancer	6.01e-05	0.000174	CcSEcCtD
Sotalol—Abdominal pain—Methotrexate—breast cancer	6.01e-05	0.000174	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Doxorubicin—breast cancer	6e-05	0.000174	CcSEcCtD
Sotalol—Insomnia—Doxorubicin—breast cancer	5.96e-05	0.000173	CcSEcCtD
Sotalol—Paraesthesia—Doxorubicin—breast cancer	5.91e-05	0.000172	CcSEcCtD
Sotalol—Dyspnoea—Doxorubicin—breast cancer	5.87e-05	0.00017	CcSEcCtD
Sotalol—Somnolence—Doxorubicin—breast cancer	5.85e-05	0.00017	CcSEcCtD
Sotalol—Gastrointestinal pain—Epirubicin—breast cancer	5.82e-05	0.000169	CcSEcCtD
Sotalol—Dyspepsia—Doxorubicin—breast cancer	5.8e-05	0.000168	CcSEcCtD
Sotalol—Decreased appetite—Doxorubicin—breast cancer	5.72e-05	0.000166	CcSEcCtD
Sotalol—Fatigue—Doxorubicin—breast cancer	5.68e-05	0.000165	CcSEcCtD
Sotalol—Pain—Doxorubicin—breast cancer	5.63e-05	0.000163	CcSEcCtD
Sotalol—Body temperature increased—Epirubicin—breast cancer	5.63e-05	0.000163	CcSEcCtD
Sotalol—Abdominal pain—Epirubicin—breast cancer	5.63e-05	0.000163	CcSEcCtD
Sotalol—Asthenia—Methotrexate—breast cancer	5.46e-05	0.000158	CcSEcCtD
Sotalol—Gastrointestinal pain—Doxorubicin—breast cancer	5.38e-05	0.000156	CcSEcCtD
Sotalol—Pruritus—Methotrexate—breast cancer	5.38e-05	0.000156	CcSEcCtD
Sotalol—Body temperature increased—Doxorubicin—breast cancer	5.21e-05	0.000151	CcSEcCtD
Sotalol—Abdominal pain—Doxorubicin—breast cancer	5.21e-05	0.000151	CcSEcCtD
Sotalol—Diarrhoea—Methotrexate—breast cancer	5.2e-05	0.000151	CcSEcCtD
Sotalol—Asthenia—Epirubicin—breast cancer	5.11e-05	0.000148	CcSEcCtD
Sotalol—Pruritus—Epirubicin—breast cancer	5.03e-05	0.000146	CcSEcCtD
Sotalol—Dizziness—Methotrexate—breast cancer	5.03e-05	0.000146	CcSEcCtD
Sotalol—Diarrhoea—Epirubicin—breast cancer	4.87e-05	0.000141	CcSEcCtD
Sotalol—Vomiting—Methotrexate—breast cancer	4.84e-05	0.00014	CcSEcCtD
Sotalol—Rash—Methotrexate—breast cancer	4.79e-05	0.000139	CcSEcCtD
Sotalol—Dermatitis—Methotrexate—breast cancer	4.79e-05	0.000139	CcSEcCtD
Sotalol—Headache—Methotrexate—breast cancer	4.76e-05	0.000138	CcSEcCtD
Sotalol—Asthenia—Doxorubicin—breast cancer	4.72e-05	0.000137	CcSEcCtD
Sotalol—Dizziness—Epirubicin—breast cancer	4.71e-05	0.000137	CcSEcCtD
Sotalol—Pruritus—Doxorubicin—breast cancer	4.66e-05	0.000135	CcSEcCtD
Sotalol—Vomiting—Epirubicin—breast cancer	4.52e-05	0.000131	CcSEcCtD
Sotalol—Nausea—Methotrexate—breast cancer	4.52e-05	0.000131	CcSEcCtD
Sotalol—Diarrhoea—Doxorubicin—breast cancer	4.51e-05	0.000131	CcSEcCtD
Sotalol—Rash—Epirubicin—breast cancer	4.49e-05	0.00013	CcSEcCtD
Sotalol—Dermatitis—Epirubicin—breast cancer	4.48e-05	0.00013	CcSEcCtD
Sotalol—Headache—Epirubicin—breast cancer	4.46e-05	0.000129	CcSEcCtD
Sotalol—Dizziness—Doxorubicin—breast cancer	4.35e-05	0.000126	CcSEcCtD
Sotalol—Nausea—Epirubicin—breast cancer	4.23e-05	0.000123	CcSEcCtD
Sotalol—Vomiting—Doxorubicin—breast cancer	4.19e-05	0.000121	CcSEcCtD
Sotalol—Rash—Doxorubicin—breast cancer	4.15e-05	0.00012	CcSEcCtD
Sotalol—Dermatitis—Doxorubicin—breast cancer	4.15e-05	0.00012	CcSEcCtD
Sotalol—Headache—Doxorubicin—breast cancer	4.13e-05	0.00012	CcSEcCtD
Sotalol—Nausea—Doxorubicin—breast cancer	3.91e-05	0.000113	CcSEcCtD
Sotalol—ADRB2—Signaling Pathways—VEGFC—breast cancer	2.04e-05	0.000477	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—WNT1—breast cancer	2.02e-05	0.000473	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PLA2G4A—breast cancer	2.02e-05	0.000472	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—JAG2—breast cancer	2.01e-05	0.00047	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CSF2—breast cancer	2e-05	0.000467	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—WNT1—breast cancer	1.98e-05	0.000463	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PLA2G4A—breast cancer	1.98e-05	0.000462	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CSF2—breast cancer	1.95e-05	0.000457	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH4—breast cancer	1.92e-05	0.000449	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—GZMB—breast cancer	1.91e-05	0.000446	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH4—breast cancer	1.88e-05	0.000439	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—GZMB—breast cancer	1.87e-05	0.000436	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL2—breast cancer	1.85e-05	0.000433	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGTR2—breast cancer	1.85e-05	0.000433	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTHLH—breast cancer	1.83e-05	0.000428	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—BMP2—breast cancer	1.83e-05	0.000428	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGTR2—breast cancer	1.81e-05	0.000424	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL2—breast cancer	1.81e-05	0.000424	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTHLH—breast cancer	1.79e-05	0.000419	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—BMP2—breast cancer	1.79e-05	0.000419	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EDNRB—breast cancer	1.77e-05	0.000415	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PGR—breast cancer	1.76e-05	0.00041	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—THBS1—breast cancer	1.75e-05	0.000408	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EDNRB—breast cancer	1.73e-05	0.000406	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PGR—breast cancer	1.72e-05	0.000401	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—THBS1—breast cancer	1.71e-05	0.000399	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FLT1—breast cancer	1.67e-05	0.00039	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF3—breast cancer	1.66e-05	0.000388	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SQSTM1—breast cancer	1.66e-05	0.000388	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CG—breast cancer	1.65e-05	0.000386	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—JAG1—breast cancer	1.64e-05	0.000383	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH3—breast cancer	1.63e-05	0.000382	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PARP1—breast cancer	1.63e-05	0.000382	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FLT1—breast cancer	1.63e-05	0.000381	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF3—breast cancer	1.62e-05	0.00038	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SQSTM1—breast cancer	1.62e-05	0.00038	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CG—breast cancer	1.62e-05	0.000378	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CALCA—breast cancer	1.61e-05	0.000377	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—JAG1—breast cancer	1.6e-05	0.000375	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH3—breast cancer	1.6e-05	0.000373	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PARP1—breast cancer	1.6e-05	0.000373	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RPS6—breast cancer	1.59e-05	0.000372	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF4—breast cancer	1.58e-05	0.00037	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CALCA—breast cancer	1.58e-05	0.000369	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCR4—breast cancer	1.57e-05	0.000368	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL12—breast cancer	1.57e-05	0.000368	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RPS6—breast cancer	1.56e-05	0.000364	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF4—breast cancer	1.55e-05	0.000361	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PAK1—breast cancer	1.55e-05	0.000361	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCR4—breast cancer	1.54e-05	0.00036	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL12—breast cancer	1.54e-05	0.00036	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TCF7L2—breast cancer	1.52e-05	0.000355	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PAK1—breast cancer	1.51e-05	0.000353	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT2—breast cancer	1.51e-05	0.000353	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CG—breast cancer	1.5e-05	0.000351	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TCF7L2—breast cancer	1.49e-05	0.000347	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT2—breast cancer	1.48e-05	0.000346	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	1.47e-05	0.000343	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HSP90AA1—breast cancer	1.46e-05	0.000342	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH2—breast cancer	1.46e-05	0.000342	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CD—breast cancer	1.45e-05	0.000339	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH2—breast cancer	1.43e-05	0.000335	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	1.43e-05	0.000335	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AGTR1—breast cancer	1.42e-05	0.000333	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PRL—breast cancer	1.42e-05	0.000333	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	1.42e-05	0.000332	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STK11—breast cancer	1.4e-05	0.000328	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ADAM10—breast cancer	1.4e-05	0.000328	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PRL—breast cancer	1.39e-05	0.000326	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AGTR1—breast cancer	1.39e-05	0.000326	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PLG—breast cancer	1.39e-05	0.000324	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STK11—breast cancer	1.37e-05	0.000321	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ADAM10—breast cancer	1.37e-05	0.000321	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT2—breast cancer	1.37e-05	0.000321	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF10—breast cancer	1.37e-05	0.000319	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PLG—breast cancer	1.36e-05	0.000317	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT2—breast cancer	1.34e-05	0.000314	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF10—breast cancer	1.34e-05	0.000312	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CD—breast cancer	1.32e-05	0.000308	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PDGFA—breast cancer	1.32e-05	0.000308	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFBR2—breast cancer	1.3e-05	0.000304	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	1.29e-05	0.000302	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PDGFA—breast cancer	1.29e-05	0.000301	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ITPR1—breast cancer	1.28e-05	0.000299	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFBR2—breast cancer	1.27e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ERBB4—breast cancer	1.27e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP3—breast cancer	1.27e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT5A—breast cancer	1.27e-05	0.000297	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CB—breast cancer	1.27e-05	0.000296	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ITPR1—breast cancer	1.25e-05	0.000292	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT5A—breast cancer	1.24e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ERBB4—breast cancer	1.24e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP3—breast cancer	1.24e-05	0.00029	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	1.24e-05	0.000289	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SMAD4—breast cancer	1.23e-05	0.000287	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1R—breast cancer	1.22e-05	0.000286	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—CXCL8—breast cancer	1.22e-05	0.000284	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SMAD4—breast cancer	1.2e-05	0.000281	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HES1—breast cancer	1.2e-05	0.000281	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1R—breast cancer	1.2e-05	0.000279	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NCOR1—breast cancer	1.19e-05	0.000279	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PLA2G4A—breast cancer	1.19e-05	0.000279	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	1.19e-05	0.000278	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CSF2—breast cancer	1.18e-05	0.000276	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGF1—breast cancer	1.18e-05	0.000276	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—RAF1—breast cancer	1.18e-05	0.000275	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HES1—breast cancer	1.17e-05	0.000274	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NRG1—breast cancer	1.17e-05	0.000274	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NCOR1—breast cancer	1.17e-05	0.000273	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	1.17e-05	0.000273	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—H2AFX—breast cancer	1.16e-05	0.000272	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—IL2—breast cancer	1.16e-05	0.000272	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—E2F1—breast cancer	1.15e-05	0.00027	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CSF2—breast cancer	1.15e-05	0.00027	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGF1—breast cancer	1.15e-05	0.00027	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—RAF1—breast cancer	1.15e-05	0.000269	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	1.15e-05	0.000269	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NRG1—breast cancer	1.15e-05	0.000268	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—H2AFX—breast cancer	1.14e-05	0.000266	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—IL2—breast cancer	1.14e-05	0.000266	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—E2F1—breast cancer	1.13e-05	0.000264	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	1.12e-05	0.000263	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SPP1—breast cancer	1.11e-05	0.000259	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—CXCL8—breast cancer	1.1e-05	0.000258	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ERBB3—breast cancer	1.1e-05	0.000257	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGFR2—breast cancer	1.1e-05	0.000256	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SPP1—breast cancer	1.09e-05	0.000254	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—CXCL8—breast cancer	1.08e-05	0.000253	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ERBB3—breast cancer	1.07e-05	0.000251	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGFR2—breast cancer	1.07e-05	0.000251	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL2—breast cancer	1.06e-05	0.000247	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TERT—breast cancer	1.05e-05	0.000246	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL2—breast cancer	1.03e-05	0.000241	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TERT—breast cancer	1.03e-05	0.000241	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FGFR1—breast cancer	1.02e-05	0.000239	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HIF1A—breast cancer	1.01e-05	0.000235	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FGFR1—breast cancer	9.99e-06	0.000234	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HIF1A—breast cancer	9.84e-06	0.00023	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—LEP—breast cancer	9.82e-06	0.00023	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CAV1—breast cancer	9.73e-06	0.000227	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KDR—breast cancer	9.62e-06	0.000225	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—LEP—breast cancer	9.6e-06	0.000225	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CAV1—breast cancer	9.52e-06	0.000222	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KDR—breast cancer	9.41e-06	0.00022	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ESR1—breast cancer	9.37e-06	0.000219	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—FN1—breast cancer	9.26e-06	0.000216	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ESR1—breast cancer	9.17e-06	0.000214	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	9.15e-06	0.000214	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	9.06e-06	0.000212	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—FN1—breast cancer	9.06e-06	0.000212	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	8.95e-06	0.000209	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	8.86e-06	0.000207	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	8.86e-06	0.000207	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KIT—breast cancer	8.86e-06	0.000207	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—APC—breast cancer	8.86e-06	0.000207	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGF—breast cancer	8.76e-06	0.000205	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	8.67e-06	0.000203	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—APC—breast cancer	8.67e-06	0.000203	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KIT—breast cancer	8.67e-06	0.000203	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGF—breast cancer	8.57e-06	0.0002	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	8.49e-06	0.000198	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—BRAF—breast cancer	8.33e-06	0.000195	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	8.3e-06	0.000194	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—BRAF—breast cancer	8.15e-06	0.00019	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IGF1—breast cancer	8.11e-06	0.00019	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT2—breast cancer	8.11e-06	0.00019	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—EGFR—breast cancer	8.07e-06	0.000189	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IGF1—breast cancer	7.94e-06	0.000186	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT2—breast cancer	7.93e-06	0.000185	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—EGFR—breast cancer	7.9e-06	0.000185	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	7.79e-06	0.000182	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	7.71e-06	0.00018	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	7.7e-06	0.00018	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—KRAS—breast cancer	7.63e-06	0.000178	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	7.62e-06	0.000178	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	7.55e-06	0.000176	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	7.54e-06	0.000176	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—KRAS—breast cancer	7.46e-06	0.000174	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—NOS3—breast cancer	7.35e-06	0.000172	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—NOS3—breast cancer	7.19e-06	0.000168	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	7.01e-06	0.000164	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MDM2—breast cancer	6.98e-06	0.000163	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RAF1—breast cancer	6.95e-06	0.000163	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—RELA—breast cancer	6.92e-06	0.000162	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—ERBB2—breast cancer	6.88e-06	0.000161	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	6.85e-06	0.00016	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MDM2—breast cancer	6.83e-06	0.00016	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RAF1—breast cancer	6.8e-06	0.000159	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MTOR—breast cancer	6.79e-06	0.000159	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	6.79e-06	0.000159	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—RELA—breast cancer	6.77e-06	0.000158	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—ERBB2—breast cancer	6.73e-06	0.000157	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MTOR—breast cancer	6.64e-06	0.000155	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	6.64e-06	0.000155	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CXCL8—breast cancer	6.52e-06	0.000153	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—HRAS—breast cancer	6.48e-06	0.000152	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CXCL8—breast cancer	6.38e-06	0.000149	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	6.37e-06	0.000149	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—HRAS—breast cancer	6.34e-06	0.000148	CbGpPWpGaD
Sotalol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	6.3e-06	0.000147	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CASP3—breast cancer	6.24e-06	0.000146	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL2—breast cancer	6.23e-06	0.000146	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	6.23e-06	0.000146	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—IL6—breast cancer	6.2e-06	0.000145	CbGpPWpGaD
Sotalol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	6.17e-06	0.000144	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CASP3—breast cancer	6.11e-06	0.000143	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL2—breast cancer	6.1e-06	0.000143	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CCND1—breast cancer	6.08e-06	0.000142	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—IL6—breast cancer	6.07e-06	0.000142	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—JUN—breast cancer	6.07e-06	0.000142	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	6.02e-06	0.000141	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CCND1—breast cancer	5.95e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—JUN—breast cancer	5.93e-06	0.000139	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MMP9—breast cancer	5.9e-06	0.000138	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	5.89e-06	0.000138	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	5.88e-06	0.000137	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PTEN—breast cancer	5.87e-06	0.000137	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MMP9—breast cancer	5.77e-06	0.000135	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	5.75e-06	0.000134	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK8—breast cancer	5.74e-06	0.000134	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PTEN—breast cancer	5.74e-06	0.000134	CbGpPWpGaD
Sotalol—ADRB1—Signaling by GPCR—AKT1—breast cancer	5.72e-06	0.000134	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK8—breast cancer	5.61e-06	0.000131	CbGpPWpGaD
Sotalol—ADRB2—Signaling by GPCR—AKT1—breast cancer	5.6e-06	0.000131	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—SRC—breast cancer	5.44e-06	0.000127	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—SRC—breast cancer	5.32e-06	0.000124	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—VEGFA—breast cancer	5.3e-06	0.000124	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—STAT3—breast cancer	5.25e-06	0.000123	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—VEGFA—breast cancer	5.18e-06	0.000121	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—STAT3—breast cancer	5.13e-06	0.00012	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MAPK3—breast cancer	5.01e-06	0.000117	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MAPK3—breast cancer	4.9e-06	0.000115	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—MYC—breast cancer	4.88e-06	0.000114	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TGFB1—breast cancer	4.86e-06	0.000114	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—MYC—breast cancer	4.77e-06	0.000112	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—EGFR—breast cancer	4.77e-06	0.000111	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TGFB1—breast cancer	4.76e-06	0.000111	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—EGFR—breast cancer	4.66e-06	0.000109	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—KRAS—breast cancer	4.5e-06	0.000105	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—KRAS—breast cancer	4.41e-06	0.000103	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	4.14e-06	9.68e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	4.05e-06	9.47e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—TP53—breast cancer	4e-06	9.36e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—TP53—breast cancer	3.92e-06	9.16e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—HRAS—breast cancer	3.83e-06	8.95e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—HRAS—breast cancer	3.75e-06	8.76e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—IL6—breast cancer	3.66e-06	8.57e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—IL6—breast cancer	3.58e-06	8.38e-05	CbGpPWpGaD
Sotalol—ADRB1—Signaling Pathways—AKT1—breast cancer	3.38e-06	7.9e-05	CbGpPWpGaD
Sotalol—ADRB2—Signaling Pathways—AKT1—breast cancer	3.31e-06	7.73e-05	CbGpPWpGaD
